ARCHIVES

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

This article is from The Cancer Letter archive.

Vol. 12 No. 07 | February 14, 1986

Download PDF Visit The Full Archive

Related Articles

NCI Finds Physician Recommendation Drives Patient Demand For ABMT

July 19, 1996

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004

Karlan To Succeed Hoskins As Chairman, DOD Ovarian Cancer Program Advisory Panel.

July 27, 2001

Senate Democrats Include $1 Billion Boost To NIH In Economic Stimulus Package.

November 21, 2008

NCI Cooperative Group Clinical Trials Approved

October 30, 2009

Breast Cancer Reports “Informative,” More Research Is Needed: Gullino

December 3, 1976